TONIX PHARMACEUTICALS HOLDIN (TNXP)

US8902608475 - Common Stock

0.6116  +0.04 (+7.3%)

After market: 0.5155 -0.1 (-15.71%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
7.768M12.795M
64.71%
15.929M
24.49%
41.708M
161.84%
EBITDA
YoY % growth
-92.26M
-82.77%
-110.84M
-20.14%
-114.089M
-2.93%
N/AN/AN/A
EBIT
YoY % growth
-92.31M
-82.76%
-112.09M
-21.43%
-118.38M
-5.61%
-84.186M
28.88%
-78.094M
7.24%
-64.577M
17.31%
Operating Margin
N/AN/A-1,523.94%-657.96%-490.26%-154.83%
EPS
YoY % growth
-1,664.00
63.89%
-814.00
51.08%
-275.84
66.11%
-14.41
94.78%
-23.03
-59.84%
-0.83
96.41%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-3.03
88.99%
-5.55
3.67%
-5.55
71.22%
-5.71
-2,383.48%
-5.55
-83.16%
Revenue
Q2Q % growth
3.468M
-8.23%
4.182M
68.49%
4.743M
114.81%
4.743M
68.07%
5.304M
52.94%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-21.308M
22.03%
-20.375M
4.57%
-21.26M
-15.80%
-21.871M
-40.61%
-25.079M
-17.70%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.23
99.61%
-2.992.7692.31%
Q2 2024
Q2Q % growth
-19.28
77.52%
-3.34-15.94-477.45%
Q1 2024
Q2Q % growth
-5.76
94.46%
-12.736.9754.75%
Q4 2023
Q2Q % growth
-27.52
75.43%
-53.6426.1248.69%
Q3 2023
Q2Q % growth
-58.56
57.57%
-48.63-9.93-20.41%
Q2 2023
Q2Q % growth
-85.76
64.85%
-89.924.164.63%
Q1 2023
Q2Q % growth
-104.00
67.50%
-98.94-5.06-5.11%
Q4 2022
Q2Q % growth
-112.00
75.00%
-175.4463.4436.16%
Q3 2022
Q2Q % growth
-138.00
56.88%
-208.0870.0833.68%
Q2 2022
Q2Q % growth
-244.00
45.54%
-294.7850.7817.23%
Q1 2022
Q2Q % growth
-320.00
28.57%
-304.66-15.34-5.03%
Q4 2021
Q2Q % growth
-448.00
30.00%
-391.68-56.32-14.38%
Q3 2021
Q2Q % growth
-320.00
44.44%
-456.96136.9629.97%
Q2 2021
Q2Q % growth
-448.00
69.57%
-424.32-23.68-5.58%
Q1 2021
Q2Q % growth
-448.00
76.67%
-359.04-88.96-24.78%
Q4 2020
Q2Q % growth
-640.00
96.50%
-489.60-150.40-30.72%
Q3 2020
Q2Q % growth
-576.00
98.42%
-718.08142.0819.79%
Q2 2020
Q2Q % growth
-1,472.00
97.58%
-1,468.80-3.20-0.22%
Q1 2020
Q2Q % growth
-1,920.00
97.67%
-2,056.32136.326.63%
Q4 2019
Q2Q % growth
-18,304.00
95.31%
-9,726.72-8,577.28-88.18%
Q3 2019
Q2Q % growth
-36,416.00
90.02%
-28,396.80-8,019.20-28.24%
Q2 2019
Q2Q % growth
-60,800.00
86.99%
-64,409.823,609.825.60%
Q1 2019
Q2Q % growth
-82,560.00
85.34%
-70,502.40-12,057.60-17.10%
Q4 2018
Q2Q % growth
-390,400.00 -239,142.18-151,257.82-63.25%
Q3 2018
Q2Q % growth
-364,800.00 -393,312.0028,512.007.25%
Q2 2018
Q2Q % growth
-467,200.00 -518,976.0051,776.009.98%
Q1 2018
Q2Q % growth
-563,200.00 -456,960.00-106,240.00-23.25%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.822M
-29.26%
3.145M-323K-10.27%
Q2 2024
Q2Q % growth
2.208M 3.57M-1.362M-38.15%
Q1 2024
Q2Q % growth
2.482M 3.876M-1.394M-35.96%
Q4 2023
Q2Q % growth
3.779M 3.91M-131K-3.35%
Q3 2023
Q2Q % growth
3.989M 5.916M-1.927M-32.57%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-89.17% -89.17% 0% 5.44%
Revenue-60.92% -60.92% 0% -11.02%